3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Vitamin D Deficiency
3
Prostatic Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
2
Triple Negative Breast Neoplasms
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Psoriasis
1
Osteoporosis Secondary
1
Osteoarthritis
1
Obesity
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Primary Cutaneous Anaplastic Large Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Immunoblastic Lymphadenopathy
1
Fractures, Stress
1
Enteropathy-Associated T-Cell Lymphoma
1
Colorectal Adenocarcinoma
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Intraductal, Noninfiltrating
1
Bone Metabolism Biomarkers
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Cholecalciferol
×
1 year
×
Clear all
No trials found.